Advertisement

Acetylator Phenotype in Behçet’s Disease

  • Rafid A. Najim
  • Khalifa E. Sharquie
  • Mahmood H. Al-Janabi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 528)

Keywords

Acetylator Status Acetylator Phenotype Autosomal Dominant Allele Rapid Acetylators Expect Genotype Frequency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weber, W.W., and Hein, D.W., 1985, N-acetylation pharmacogenetics. Pharmacol. Rev. 37: 25–79.PubMedGoogle Scholar
  2. 2.
    Chen, M.L., Lee M.G., and Chiou W.L., 1983, Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effects of blood samples. J. Pharma. Sci. 72: 572–574.Google Scholar
  3. 3.
    Sharquie, K.E., 1990, Behçet’s disease. Postgrad. Doctor Middle East 13: 186–190.Google Scholar
  4. 4.
    Behçet, H., 1937, Über rezidivierende aphthöse, durch ein virus verursachte Geschwüre am Mund am Auge und den Genitalien. Dermatol. Wochenschr. 105: 1152–1157.Google Scholar
  5. 5.
    Sharquie K., 1984, Suppression of Behçet’s disease with dapsone. Br. J. Dermatol. 110: 493–494.PubMedGoogle Scholar
  6. 6.
    Sharquie, K., Najim, R.A., and Abu-Raghif, A.R., 2002, Dapsone in treatment of Behçet’s disease: a double blind, placebo-controlled crossover study. J. Dermatol., in press.Google Scholar
  7. 7.
    International Study Group for Behçet’s disease, 1990, Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080.Google Scholar
  8. 8.
    Philip, P.A., Gayed, S.L., and Rogers, H.J., 1984, A rapid method for determination of acetylation phenotype using dapsone. Br. J. Clin. Pharmacol. 17: 465–469.PubMedGoogle Scholar
  9. 9.
    Sorlie, D.E., 1995, Medical Biostatistics and Epidemiology: Examination and Board review. 1st ed., Appleton and Lange, Norwalk, Connecticut, pp. 47–88.Google Scholar
  10. 10.
    Friedman, J.M., 1996, Population genetics. In Genetics (Friedman, J.M., ed.), 2nd ed., pp. 105–111.Google Scholar
  11. 11.
    Ahmad, R.A., 1984, Acetylation in Iraqi population. In Proceeding of the First Scientific Congress, College of Medicine, University of Baghdad, p. 115.Google Scholar
  12. 12.
    Irashaid, Y.M., Al-Hadidi H.F., Aburijeie, M.A., et al., 1991, N-acetylation phenotyping using dapsone in a Jordanian population. Br. J. Clin. Pharmacol. 32: 289–293.Google Scholar
  13. 13.
    Islam, S.I., 1982, Polymorphic acetylation of sulphamethazine in rural Bedouin and urban dwellers in Saudi Arabia. Xenobiotica 12: 323–328.PubMedGoogle Scholar
  14. 14.
    Karim, A.K.M.B., Elferah, M.S., and Evans, D.A.P., 1981, Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution. J. Med. Genet. 18: 325–330.PubMedGoogle Scholar
  15. 15.
    Hashem, N., Khalifa, S., and Nour, A., 1969, The frequency of isoniazide acetylase enzyme deficiency among Egyptians. Am. J. Phys. Anthropol. 31: 97–102.CrossRefPubMedGoogle Scholar
  16. 16.
    Grant, D.M., Tang, B.K., and Kalow, W., 1983, Polymorphic N-acetylation of a caffeine metabolite. Clin. Pharmacol. Ther. 33: 355–359.PubMedGoogle Scholar
  17. 17.
    Horai, Y., and Ishizaki, T., 1988, N-acetylation polymorphism of dapsone in a Japanese population. Br. J. Clin. Pharmacol. 25: 487–494.PubMedGoogle Scholar
  18. 18.
    El-Yazigi, A., Chaleby, K., and Martin, C.R., 1989, Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test. J. Clin. Pharmacol. 29: 246–250.PubMedGoogle Scholar
  19. 19.
    Yazici, H., Chamberlain, M.A., Schreuder, T., et al., 1980, HLA antigen in Behçet’s disease: A reapprasial by a comperative study of Turkish and British patients. Ann. Rheum. Dis. 39: 344.PubMedGoogle Scholar
  20. 20.
    Al-Rawi, Z.S., Sharquie, K.E., Khalifa, S.J., et al., 1986, Behçet’s disease in Iraqi patients. Ann. Rheum. Dis. 45: 987–990.PubMedGoogle Scholar
  21. 21.
    Evans D.A.P., Manley K.A., and Mckusick, V.A., 1960, Genetic control of isoniazide metabolism in man. Br. Med. J. 2: 458–491.Google Scholar
  22. 22.
    Zuidema, J., Hilbers, E.S., and Merkus A., 1986, Clinical pharmacokinetics of dapsone. Clin. Pharmacokinet. 11: 299–314.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Rafid A. Najim
    • 1
  • Khalifa E. Sharquie
    • 2
  • Mahmood H. Al-Janabi
    • 1
  1. 1.Department of Pharmacology College of MedicineUniversity of BaghdadBaghdadIraq
  2. 2.Department of Dermatology, College of MedicineUniversity of BaghdadBaghdadIraq

Personalised recommendations